Inhibition of Platelet‐Collagen Interaction An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2002-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HQ0102.101546PMID 11788478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.

  2001cited by this paper
• Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen

  2001cited by this paper
• Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets.

  2001cited by this paper
• Mononuclear cell adhesion to collagen ex vivo is related to pulse pressure in elderly subjects.

  2000cited by this paper
• Stimulation of nitric oxide synthesis and protective role of insulin in acute thrombosis in vivo.

  1999cited by this paper
• Influence of fibrillar collagen structure on the mechanisms of platelet thrombus formation under flow.

  1999cited by this paper
• Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention.

  1999cited by this paper
• Studies of adhesion-dependent platelet activation: distinct roles for different participating receptors can be dissociated by proteolysis of collagen.

  1999cited by this paper
• Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.

  1999cited by this paper
• Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction

  1999cited by this paper
• PFA-100™ System: A New Method for Assessment of Platelet Dysfunction

  1998cited by this paper
• Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells

  1998cited by this paper
• Platelet Resistance to Nitrates in Obesity and Obese NIDDM, and Normal Platelet Sensitivity to Both Insulin and Nitrates in Lean NIDDM

  1998cited by this paper
• Factor Xa generation at the surface of cultured rat vascular smooth muscle cells in an in vitro flow system.

  1998cited by this paper
• Platelet Adhesion to Collagen: an Update

  1997cited by this paper
• Inhibitory effects of insulin on intracellular calcium and aggregatory response of platelets are impaired in hypertensive subjects with insulin resistance.

  1997cited by this paper
• Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

  1997cited by this paper
• In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance.

  1996cited by this paper
• Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

  1996cited by this paper
• Epinephrine Augments Platelet Recruitment to Immobilized Collagen in Flowing Blood - Evidence for a von Willebrand Factor-mediated Mechanism

  1996cited by this paper
• Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects

  1995cited by this paper
• Impaired Insulin-Induced Platelet Antiaggregating Effect in Obesity and In obese NIDDM Patients

  1995cited by this paper
• Blunted inhibition by insulin of agonist‐stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients

  1994cited by this paper
• Role of cyclic nucleotides in rapid platelet adhesion to collagen.

  1994cited by this paper
• Inhibition by nitroprusside of platelet calcium mobilization: evidence for reduced sensitivity to nitric oxide in essential hypertension

  1993cited by this paper
• Evidence for altered platelet nitric oxide synthesis in essential hypertension

  1993cited by this paper
• Insulin Directly Reduces Platelet Sensitivity to Aggregating Agents: Studies In Vitro and In Vivo

  1988cited by this paper
• Low‐density lipoprotein enhances platelet activation in parallel with the height of blood pressure

  1988cited by this paper
• The platelet insulin receptor: detection, partial characterization, and search for a function.

  1988cited by this paper
• Reduction of platelet aggregation induced by euglycaemic insulin clamp

  1987cited by this paper
• Assessment of fat-free mass using bioelectrical impedance measurements of the human body.

  1985cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.

  1971cited by this paper
• A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption

  1968cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper

• Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of CYP2C19 loss-of-function mutations

  2026cites this paper
• Platelet Distribution Width in Diabetic Nephropathy: A Cross Sectional study

  2024cites this paper
• Heparinized collagen-based hydrogels for tissue engineering: physical, mechanical and biological properties.

  2024cites this paper
• Blood coagulation in Prediabetes clusters–impact on all-cause mortality in individuals undergoing coronary angiography

  2024cites this paper
• Association between mean platelet volume and the risk of type 2 diabetes mellitus among women with history of gestational diabetes mellitus

  2024cites this paper
• Investigating the Hematological Indices in Children With Type I Diabetes Mellitus: A Review Article

  2024cites this paper
• The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections

  2024cites this paper
• Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium

  2023cites this paper
• Role of mean platelet volume in patients with type 2 diabetes mellitus

  2023cites this paper
• Capturing effects of blood flow on the transplanted decellularized nephron with intravital microscopy

  2023cites this paper
• The Cellular and Protein Arms of Coagulation in Diabetes: Established and Potential Targets for the Reduction of Thrombotic Risk

  2023cites this paper
• Insulin Resistance-Induced Platelet Hyperactivity and a Potential Biomarker Role of Platelet Parameters: A Narrative Review

  2023cites this paper
• Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease

  2023cites this paper
• Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease

  2022cites this paper
• Pathophysiological disorders in iron metabolism in the development of obesity and metabolic syndrome

  2022cites this paper
• Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets

  2022cites this paper
• Type 2 Diabetes Mellitus, Platelet Activation and Alzheimer’s Disease: A Possible Connection

  2022cites this paper
• Mean platelet volume and glycaemic control in patients with new-onset Type 2 diabetes mellitus

  2022cites this paper
• The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance

  2022cites this paper
• Correlation of aspirin resistance with serological indicators in patients with coronary heart disease in the plateau.

  2021cites this paper
• Lifestyle intervention improves prothrombotic coagulation profile in individuals at high-risk for type 2 diabetes.

  2021cites this paper
• Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation

  2021cites this paper
• PLATELET INDICES AS A TOOL IN ASSESSING THE PROGRESSION OF TYPE 2 DIABETES MELLITUS

  2020cites this paper
• Influence of Cardiometabolic Risk Factors on Platelet Function

  2020cites this paper
• Avoiding cardiovascular disease in type1and type2 Diabetes Mellitus by targeting the coagulatory Alterations A Systematic Review

  2020cites this paper
• The Effect of Empagliflozin on Platelet Function Profiles in Patients with Stable Coronary Artery Disease in Trinidad: The EFFECT Pilot Study

  2020cites this paper
• Iron Metabolism in Obesity and Metabolic Syndrome

  2020cites this paper
• Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection

  2020cites this paper
• The association between platelet/lymphocyte ratio, neutrophil/lymphocyte ratio, and carotid artery stenosis and stroke following carotid endarterectomy

  2019cites this paper
• Platelet indices in type 1 diabetes mellitus

  2019cites this paper
• Moringa oleifera ameliorates lipid metabolic disorders , oxidative stress and the inflammatory status in high fat diet-induced obesity in rats

  2019cites this paper
• Mean Platelet Volume – Predictor of Impending Diabetic Vascular Complications

  2019cites this paper
• Risk stratification for thrombosis in type 2 diabetic patients

  2019cites this paper
• Coagulatory Defects in Type-1 and Type-2 Diabetes

  2019cites this paper
• Hypoglycaemia induced platelet function in T 2 DM

  2019cites this paper
• Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies

  2018cites this paper
• Chapter 9 Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

  2018cites this paper
• The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation

  2018cites this paper
• Platelet Function in Inflammatory Arthritis

  2018cites this paper
• Platelet function following induced hypoglycaemia in type 2 diabetes.

  2018cites this paper
• Moringa Oleifera improve lipid metabolic disorders in obesity induced oxidative stress in rats

  2018cites this paper
• Antiobesity activity and hypolipidemic effect of Proanthocyanidins in rats fed a high fat diet

  2018cites this paper
• Thrombosis in diabetes: a shear flow effect?

  2017cites this paper
• Diabetespatienten mit kardiovaskulärer Erkrankung

  2016cites this paper
• Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy

  2016cites this paper
• Insulin Resistance in Type 2 Diabetes

  2016cites this paper
• Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

  2016cites this paper
• Pleiotropic Garlic ( Allium Sativum ) in the Treatment of Diabetes Mellitus and its Complications

  2016cites this paper
• Platelet hyperaggregability in obesity: is there a role for nitric oxide impairment and oxidative stress?

  2016cites this paper
• Preliminary Evaluation of Platelet Counts of Diabetic Individuals Attending University of Maiduguri Teaching Hospital

  2016cites this paper
• Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels.

  2016cites this paper
• Effects of nitrite and nitroxyl on human vascular and platelet function.

  2015cites this paper
• Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

  2015cites this paper
• Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation

  2015cites this paper
• State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus

  2015cites this paper
• Pyruvate attenuate lipid metabolic disorders and insulin resistance in obesity induced in rats

  2015cites this paper
• The impact of obesity on the pharmacology of medications used for cardiovascular risk factor control.

  2015cites this paper
• Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

  2015cites this paper
• Rôle des lipides oxydés dans la régulation de l'activation plaquettaire par les lipoprotéines de haute densité (HDL) plasmatiques et implication dans le diabète de type 2

  2015cites this paper
• Mechanisms of hypoglycaemia related sudden cardiac death in type 2 diabetes mellitus

  2015cites this paper
• Residual platelet reactivity in atherosclerosis and its impact on patient outcomes

  2014cites this paper
• Acute fluctuation in blood glucose has no effect on platelet aggregation rate.

  2014cites this paper
• Inflammation and atherosclerosis

  2014cites this paper
• Insulin therapy in type 2 diabetes : Initiation, impact on liver fat, role of combination therapy with glitazones or glindes

  2014cites this paper
• The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study

  2014cites this paper
• Clopidogrel-related platelet inhibition: correlation with peri-operative adverse events in neurointerventional procedures

  2014cites this paper
• Thrombosis in central obesity and metabolic syndrome: Mechanisms and epidemiology

  2013cites this paper
• Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction

  2013cites this paper
• Exacerbation of Glycoprotein VI-Dependent Platelet Responses in a Rhesus Monkey Model of Type 1 Diabetes

  2013cites this paper
• Clinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastography

  2013cites this paper
• Disorders of Hemostasis in Overt and Subclinical Hypercortisolism

  2013cites this paper
• Antithrombotic therapy in obesity

  2013cites this paper
• Effects of obesity on drug pharmacokinetics

  2013cites this paper
• Anticoagulant treatment in patients with diabetes

  2013cites this paper
• Local insulin application on the carotid artery inhibits neointima formation.

  2013cites this paper
• Curcumin acts as Cardiovascular Protector via Improving Leptin and Insulin Resistance in Obese Male Rats

  2013cites this paper
• Platelet Function Profiles in Patients with Diabetes Mellitus

  2013cites this paper
• Platelet function in the postprandial period

  2012cites this paper
• Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes

  2012cites this paper
• The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance

  2012influential citation
• Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.

  2012cites this paper
• Postprandial platelet aggregation: effects of different meals and glycemic index

  2012cites this paper
• Alterations of sympathetic nervous system, coagulation and platelet function in gestational diabetes

  2012cites this paper
• Effects of insulin on the vasculature.

  2011cites this paper
• Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

  2011cites this paper
• A Novel Small Molecule 1,2,3,4,6-penta-O-galloyl-α-D-glucopyranose Mimics the Antiplatelet Actions of Insulin

  2011cites this paper
• Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles

  2011cites this paper
• Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective

  2011cites this paper
• Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications

  2011cites this paper
• Akt signalling in health and disease.

  2011cites this paper
• Crosstalk between the sympathetic nervous system, inflammation and coagulation in gestational diabetes; a therapeutic approach in postmenopausal hypertension

  2011cites this paper
• Chronic Low-grade Inflammation and Haematological, Circulatory, Metabolic, and Hepatic Abnormalities in Childhood Obesity

  2011cites this paper
• Characteristics of Prediabetes, predictors of progression and strategies to prevent Type 2 Diabetes Mellitus in a multiethnic population in the United Kingdom

  2011cites this paper
• Inflammation and Thrombosis — Brothers in Arms

  2011cites this paper
• Composition lipidique et oxydation des lipoprot eines de basse densit e (LDL) plasmatiques en relation avec l'activation des plaquettes sanguines.

  2011cites this paper
• Vasculoprotective Effects of Insulin and Resveratrol In Vivo

  2011cites this paper
• Diabetes and Cardiovascular Disease Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

  2011cites this paper
• Syndrome métabolique et diabète chez l'Homme. Composition lipidique et oxydation des lipoprotéines de basse densité (LDL) plasmatiques en relation avec l'activation des plaquettes sanguines.

  2010cites this paper
• In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin

  2010cites this paper
• Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells

  2010cites this paper